32 results on '"Chen, Can-Ming"'
Search Results
2. Chiral Brønsted acid-catalyzed asymmetric intermolecular [4 + 2] annulation of ynamides with para-quinone methides
3. Numerical Investigation on Vortex-Induced Rotations of A Triangular Cylinder Using An Immersed Boundary Method
4. Construction of Axially Chiral Arylpyrroles via Atroposelective Diyne Cyclization
5. Supplementary Figure from Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial
6. Copper‐Catalyzed Enantioselective Doyle–Kirmse Reaction of Azide‐Ynamides via α‐Imino Copper Carbenes
7. Copper-catalyzed formal [4 + 1] annulation of N-propargyl ynamides with diketones
8. Weekly paclitaxel plus carboplatin with or without trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancer: loss of HER2 amplification and its impact on response and prognosis
9. Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial
10. Lymph Node Counts and Ratio in Axillary Dissections Following Neoadjuvant Chemotherapy for Breast Cancer: A Better Alternative to Traditional pN Staging
11. Prognostic Value of a Positive-to-negative Change in Hormone Receptor Status after Neoadjuvant Chemotherapy in Patients with Hormone Receptor–positive Breast Cancer
12. Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge
13. A prognostic model to predict outcome of patients failing to achieve pathological complete response after anthracycline-containing neoadjuvant chemotherapy for breast cancer
14. Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor‐positive, human epidermal growth factor receptor 2‐negative breast cancer (CBCSG‐036): A randomized, controlled, multicenter trial
15. Weekly paclitaxel plus carboplatin with or without trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancer: loss of HER2 amplification and its impact on response and prognosis
16. Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy
17. Abstract P1-12-02: Effect of using LHRH analog during chemotherapy (CT) on premature ovarian failure and prognosis in premenopausal patients with early-stage, hormone receptor-positive breast cancer: The primary analysis of a randomized controlled phase III trial
18. ER-Poor and HER2-Positive: A Potential Subtype of Breast Cancer to Avoid Axillary Dissection in Node Positive Patients after Neoadjuvant Chemo-Trastuzumab Therapy
19. Lymph Node Counts and Ratio in Axillary Dissections Following Neoadjuvant Chemotherapy for Breast Cancer: A Better Alternative to Traditional pN Staging
20. Weekly Paclitaxel/Carboplatin/Trastuzumab Therapy Improves Pathologic Complete Remission in Aggressive HER2‐Positive Breast Cancers, Especially in Luminal‐B Subtype, Compared With a Once‐Every‐3‐Weeks Schedule
21. Obesity or Overweight Is Associated with Worse Pathological Response to Neoadjuvant Chemotherapy among Chinese Women with Breast Cancer
22. Association of HER‐2 Copy Number and HER‐2/CEP‐17 Ratio with Neoadjuvant Taxane‐Containing Chemotherapy Sensitivity in Locally Advanced Breast Cancer
23. A prognostic model to predict outcome of patients failing to achieve pathological complete response after anthracycline-containing neoadjuvant chemotherapy for breast cancer
24. Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge
25. Construction of Axially Chiral Arylpyrroles via Atroposelective Diyne Cyclization.
26. Molecular subtype can predict the response and outcome of Chinese locally advanced breast cancer patients treated with preoperative therapy.
27. [Effect of postoperative pregnancy upon prognosis of young breast cancer patients].
28. [Study on predictors of long term results for neo-adjuvant chemotherapy in locally advanced breast cancer].
29. [A study on the relationship between breast cancer molecular classification and prognosis].
30. Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer.
31. [Stereotactic biopsy for non-palpable breast lesions: evaluation and choice of minimal invasive and excisional biopsy].
32. [A study of the combination of vinorelbine and epirubicin as neoadjuvant chemotherapy regimen in the treatment of locally advanced breast cancer].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.